Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine (LSA-3-rec)

This study has been completed.
Sponsor:
Collaborator:
Institut Pasteur
Information provided by:
Radboud University
ClinicalTrials.gov Identifier:
NCT00509158
First received: July 30, 2007
Last updated: February 22, 2010
Last verified: November 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)